BioSpace News Archive

Pharm Country

Strong Demand for M&A Driven by Segment Convergence with a Desire Among Buyers to Deepen Industry and Digital Expertise According to 5th Annual Equiteq Survey

The Knowledge Economy Global Buyers Report analyzes the findings of Equiteq’s fifth comprehensive independent survey of global strategic buyers and private equity investors acquiring businesses across the knowledge economy.

November 15, 2018
·
3 min read
Prefilled Formalin Vials Market: Growing Incidence of Cancer in Asia Pacific Due to Changing Lifestyle of People

The growth of the healthcare industry is expected to play a vital role in shaping the future prospects of the prefilled formalin vials market

November 15, 2018
·
4 min read
Drug Development

Biohaven Enrolls First Patient In Phase 3 Preventive Treatment Of Migraine Trial With Its Oral CGRP Receptor Antagonist Rimegepant

Rimegepant is the only oral CGRP receptor antagonist currently in development for both the acute and preventive treatment of migraine

November 15, 2018
·
5 min read
Policy

Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) Tablets for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib

EC approval triggers $40 million milestone payment to Exelixis under Collaboration Agreement with Ipsen

November 15, 2018
·
13 min read
Business

Medicrea Reports Third-Quarter 2018 Results

Third quarter sales increased by 14%

November 15, 2018
·
3 min read
Business

MediSapiens to Support Terveystalo With Biobank Data Management and Analytics Solutions

MediSapiens has partnered with Terveystalo, a leading private healthcare service provider in Finland, to support their biobank operations with scalable, interactive and secure genomic and clinical data solutions.

November 15, 2018
·
3 min read
Genetown

Cadent Therapeutics Secures $40 Million Series B Financing to Advance Pipeline of Novel Therapies for Movement and Cognitive Disorders

Supports Near-term Initiation of Phase 2 Essential Tremor and Spinocerebellar Ataxia Trials

November 15, 2018
·
6 min read
Business

Torrey Pines Investment’s i2020 Accelerator to Advance Snap Bio’s Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases

Torrey Pines Investment announced today that Snap Bio, Inc. has joined its early drug discovery ecosystem through its i2020 Accelerator specialty investment framework, which includes a three-way partnership with ChemDiv, Inc.

November 15, 2018
·
4 min read
Policy

European Commission approves Ipsen’s Cabometyx® (cabozantinib) for the treatment of hepatocellular carcinoma in adults previously treated with sorafenib

Ipsen today announced that the European Commission (EC) has approved Cabometyx® (cabozantinib) 20, 40, 60 mg as a monotherapy for hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib.

November 15, 2018
·
11 min read
Policy

OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues

OxThera AB today announced a granted US patent on Oxalobacter formigenes secretagogues.

November 15, 2018
·
2 min read